Mankind Pharma Limited
MANKIND
Classificação em ações
#2062
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Preço da ação
$24.08
Valor de mercado
$9.95B
Variação (1 dia)
-4.09%
Variação (1 ano)
-13.33%
País
IN
Negociar Mankind Pharma Limited (MANKIND)
Categoria
Healthcare
EPS de Mankind Pharma Limited (MANKIND)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Mankind Pharma Limited, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Mankind Pharma Limited de 2019 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2025 | $0.57 | 0.38% |
| 2024 | $0.57 | 47.07% |
| 2023 | $0.39 | -17.39% |
| 2022 | $0.47 | 9.25% |
| 2021 | $0.43 | 26.39% |
| 2020 | $0.34 | 64.21% |
| 2019 | $0.21 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
